Add to ORKGPostenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma
Objective. To assess the outcome and determine risk factors for extraocular relapse in patients with...
Retinoblastoma is the most common intraocular malignancy of childhood. Significant progress has been...
Purpose: To evaluate the effectiveness of chemoreduction (CRD) for globe saving in patients with int...
BACKGROUND: Analysis of 52 eyes with high-risk retinoblastoma managed with postenucleation adjuvant ...
PURPOSE: To evaluate a chemoreduction regimen using systemic vincristine and carboplatin (VC) and lo...
Primary enucleation is a life-saving treatment for advanced intraocular retinoblastoma, particularly...
Chemotherapy has recently achieved a major role in the primary management of intraocular retinoblast...
Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. Although enucleation a...
BACKGROUND: To assess the efficacy of chemotherapy (chemoreduction) plus local treatments as an alte...
Advanced intraocular retinoblastoma can be cured by enucleation, but spread of retinoblastoma cells ...
Retinoblastoma is the most common eye cancer in children. Pilot studies of chemotherapy for intraocu...
Background: Eye-preserving therapy in retinoblastoma comprises systemic chemotherapy, but studies an...
PURPOSE: To evaluate the efficacy of first-line chemotherapy (CT) in preventing external-beam radiot...
Abstract Introduction: Advanced intraocular retinoblastoma can be cured by enucleation, but spread o...
Treatment trends of retinoblastoma (RB) have gradually evolved from eye enucleation and external rad...
Objective. To assess the outcome and determine risk factors for extraocular relapse in patients with...
Retinoblastoma is the most common intraocular malignancy of childhood. Significant progress has been...
Purpose: To evaluate the effectiveness of chemoreduction (CRD) for globe saving in patients with int...
BACKGROUND: Analysis of 52 eyes with high-risk retinoblastoma managed with postenucleation adjuvant ...
PURPOSE: To evaluate a chemoreduction regimen using systemic vincristine and carboplatin (VC) and lo...
Primary enucleation is a life-saving treatment for advanced intraocular retinoblastoma, particularly...
Chemotherapy has recently achieved a major role in the primary management of intraocular retinoblast...
Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. Although enucleation a...
BACKGROUND: To assess the efficacy of chemotherapy (chemoreduction) plus local treatments as an alte...
Advanced intraocular retinoblastoma can be cured by enucleation, but spread of retinoblastoma cells ...
Retinoblastoma is the most common eye cancer in children. Pilot studies of chemotherapy for intraocu...
Background: Eye-preserving therapy in retinoblastoma comprises systemic chemotherapy, but studies an...
PURPOSE: To evaluate the efficacy of first-line chemotherapy (CT) in preventing external-beam radiot...
Abstract Introduction: Advanced intraocular retinoblastoma can be cured by enucleation, but spread o...
Treatment trends of retinoblastoma (RB) have gradually evolved from eye enucleation and external rad...
Objective. To assess the outcome and determine risk factors for extraocular relapse in patients with...
Retinoblastoma is the most common intraocular malignancy of childhood. Significant progress has been...
Purpose: To evaluate the effectiveness of chemoreduction (CRD) for globe saving in patients with int...